skip to content
Systematic Reviews of Treatments for Retinal Diseases
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for retinal diseases.
Reviewed December 2011
20 Resources Found
Results 1 to 20 displayed.
| Title: | Interventions for prevention of giant retinal tear in the fellow eye |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | A giant retinal tear is a full-thickness retinal break that extends for 90 degrees or more around the circumference of the retina, in the presence of posterior vitreous detachment (when the vitreous comes away from the retina). Giant retinal tears cause... |
| Date: | Dec 2011 |
| Title: | Non-steroidal anti-inflammatory drugs for treating fluid accumulation in the macula after cataract surgery |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Cystoid macular oedema (CMO) is the accumulation of fluid in the macula (central retina) due to leakage from capillaries. Clinically significant CMO following cataract surgery is a complication of unknown cause. Acute CMO, defined as oedema of less than... |
| Date: | Aug 2011 |
| Title: | Optical coherence tomography measurement of central retinal thickness to diagnose diabetic macular oedema |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Diabetic macular oedema (DMO) is a thickening of the central part of the retina, the macula, that may affect people with diabetic retinopathy (DR). Diabetic retinopathy is a complication of diabetes in which the retina (a layer of tissue at the back of ... |
| Date: | May 2011 |
| Title: | Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Postoperative vitreous cavity haemorrhage (POVCH) is a significant complication following vitrectomy (removal of the vitreous gel from the posterior chamber of the eye) for the treatment of proliferative retinopathy (the growth of abnormal blood vessels... |
| Date: | Mar 2011 |
| Title: | Antibiotics compared with no treatment or placebo for the treatment of toxoplasma retinochoroiditis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Toxoplasma retinochoroiditis occurs when a parasite called toxoplasma gondii gets into the retina (the light sensitive layer inside the eye) and the choroid (layer of the eyeball near the retina). This causes inflammation that can scar the retina and re... |
| Date: | Feb 2011 |
| Title: | Local anaesthetic eye drops for prevention of pain in preterm infants undergoing screening for retinopathy of prematurity |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Infants born less than 1500 g or less than 32 weeks are at increased risk of retinopathy of prematurity, a potentially blinding eye condition, and so have routine ophthalmological assessment. This process is a recognised source of pain and discomfort fo... |
| Date: | Nov 2010 |
| Title: | Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Retinal detachment (RD) remains a significant cause of vision loss. Most recurrent RDs are associated with varying degrees of proliferative vitreoretinopathy (PVR), or the growth of fibrous membranes (similar to scar tissue) along the surface of the ret... |
| Date: | Jul 2009 |
| Title: | Antiangiogenic therapy for diabetic macular oedema |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. The retina at the macula thickens and this can cause gradual loss of central vision. Grid or focal laser photocoagulation is effective in treating DMO and has been used for ... |
| Date: | Apr 2009 |
| Title: | Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Central retinal vein occlusion (CRVO) is the most common retinal vascular abnormality second to diabetic retinopathy. It classically presents as a unilateral painless loss of vision in individuals over the age of 40 and is associated with conditions suc... |
| Date: | Feb 2009 |
| Title: | Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | A rhegmatogenous retinal detachment develops when a break (tear, hole) occurs in the sensory retina and allows fluid from the vitreous cavity to separate the sensory retina from the underlying retinal pigment epithelium. When retinal breaks occur they m... |
| Date: | Jan 2012 |
| Title: | Treatments for acute central retinal artery occlusion (blockage of the blood supply to the retina of the eye) |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Central retinal artery occlusion occurs when the blood supply to the inner part of the retina (the light sensitive layer inside the eye) is suddenly stopped. If the blockage is removed in time, and the blood supply returns to the retina, full recovery i... |
| Date: | Sep 2008 |
| Title: | Gradual versus abrupt discontinuation of oxygen in preterm or low birth weight infants |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Not enough evidence to show the best way to wean premature babies off oxygen supplementation. Babies born either prematurely (before 37 weeks) or with a low birthweight often have breathing problems and need extra oxygen. Appropriate oxygen levels are i... |
| Date: | Aug 2008 |
| Title: | Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Restricting oxygen supplementation significantly reduces the rate and severity of vision problems (retinopathy) in premature and low birth weight babies. Babies born either prematurely (before 37 weeks) or with a low birth weight often have breathing pr... |
| Date: | Aug 2008 |
| Title: | Pentoxifylline for diabetic eye disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Diabetic retinopathy or eye disease is the leading cause of blindness in developed countries. Nowadays its treatment is based on the use of laser therapy. Since this is a procedure which destroys important cells in the eye, drug approaches have been dev... |
| Date: | Jul 2007 |
| Title: | Intravitreal steroids for macular edema in people with diabetes |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Macular edema, swelling of the center of the retina (the part of the eye responsible for our sharpest vision), is an important cause of poor vision in patients with diabetes. New forms of therapy are desirable because the current treatment including las... |
| Date: | Jun 2007 |
| Title: | Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Diabetic retinopathy or eye disease is the leading cause of blindness in developed countries. Laser therapy currently is the primary means in the treatment of diabetic retinopathy. It nevertheless is a procedure which destroys important cells in the eye... |
| Date: | Jun 2006 |
| Title: | Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Increased oxygen supplementation for babies with signs of worsening retinopathy of prematurity (ROP) may not prevent development of this eye disease, and may lead to lung complications. Very preterm babies are at risk of damage to their sight from ROP (... |
| Date: | Dec 2002 |
| Title: | Early light reduction for preventing retinopathy of prematurity in very low birth weight infants |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Retinopathy of prematurity can cause vision loss in premature infants. One theory was that bright light after birth started off the injury that led to vision loss. Considerable research has been done on this and it now appears fairly certain that bright... |
| Date: | Nov 2000 |
| Title: | D-Penicillamine for preventing retinopathy of prematurity in preterm infants |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | The eye disease of premature infants called retinopathy of prematurity continues to be a serious problem. The drug d-penicillamine, given by mouth, is used to treat iron or copper or other heavy metal poisoning. In research to learn if the drug given in... |
| Date: | Nov 2000 |
| Title: | Peripheral retinal ablation for threshold retinopathy of prematurity in preterm infants |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Advances in perinatal medicine have led to increased survival of extremely low birth weight infants and an increase in the incidence of retinopathy of prematurity (ROP). This is a vascular proliferative disorder of the immature retina in premature infan... |
Results 1 to 20 displayed.
